Sector revisions HUTCHMED (China) Limited

Equities

Delayed London S.E. Other stock markets 08:47:31 16/03/2026 pm IST			5-day change	1st Jan Change
209.90 ^GBX	-0.05%		-0.99%	+0.91%

09/03	Hutchmed (China) says Ipsen initiates market withdrawal and recall of Tazverik in China	RE
09/03	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	HUTCHMED (CHINA) LIMITED							7
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							19
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	MERCK & CO., INC.							27
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							28
	NOVO NORDISK A/S							22
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							28
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	Average							22
	Weighted average by Cap.							25